Increasing Access to Innovative Medicines
Written Submission for the Pre-Budget Consultations in Advance of the 2026 Ontario Budget January 2026
Our resource hub to discover reports, policy papers and other forms of informative content
Written Submission for the Pre-Budget Consultations in Advance of the 2026 Ontario Budget January 2026
Written Submission for the Pre-Budget Consultations in Advance of the 2026 Alberta Budget
Written Submission for the Pre-Budget Consultations in Advance of the 2026 Nova Scotia Budget
The private drug insurance market in Canada saw a 7.3% total cost growth in 2023-2024, primarily driven by increased utilization which accounted for 60% of total cost growth. The number of claimants rose by 3.5%, with claimants making
0.9% more claims.
Written Submission for the Pre-Budget Consultations in Advance of the Upcoming Federal Budget
This study examines the contribution of Canada’s research and development (R&D) pharmaceutical sector to the Canadian economy in 2022. It builds upon the annual reports produced since 2018.
Informative content to keep you up to date on the most pressing issues facing our industry.